Publication:
Studies on the chemotherapy of human opisthorchiasis in Thailand: I. Clinical trial of praziquantel

dc.contributor.authorD. Bunnagen_US
dc.contributor.authorT. Harinasutaen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-04-30T08:37:04Z
dc.date.available2018-04-30T08:37:04Z
dc.date.issued1980-12-01en_US
dc.description.abstractPraziquantel (Embay 8440) was found to be effective in eliminating egg of Opisthorchis viverrini. from the stools of 49 patients. Two regimens were used: Group I patients received 25 mg/kg body weight three times daily after meals for two consecutive days, and Group II patients received 25 mg/kg body weight three times daily after meals for one day. In both groups eggs were not detected in the faeces by day 60 and up to 4-8 months post treatment. Mild transient side-effects were present in approximately 80% of patients of Group I, with milder side effects reported in Group II. Severe diarrhoea was present on day 0 in one patient from each group. Side reactions included headache, dizziness, myalgia and lassitude; however, no laboratory evidence of toxicity was detected.en_US
dc.identifier.citationSoutheast Asian Journal of Tropical Medicine and Public Health. Vol.11, No.4 (1980), 528-531en_US
dc.identifier.issn00383619en_US
dc.identifier.other2-s2.0-0019293872en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/11139
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0019293872&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleStudies on the chemotherapy of human opisthorchiasis in Thailand: I. Clinical trial of praziquantelen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0019293872&origin=inwarden_US

Files

Collections